Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EMA grants PRIME designation to Rocket’s AAV-based gene therapy
RP-A501 is an adeno-associated virus-based gene therapy used to treat devastating and fatal inherited cardiomyopathy. Credit: Pfree2014 / commons.wikimedia.org.
RP-A501 is an adeno-associated virus-based gene therapy used to treat devastating and fatal inherited cardiomyopathy. Credit: Pfree2014 / commons.wikimedia.org.